Methyl 3-bromoimidazo[1,2-a]pyridine-7-carboxylate is used as pharmaceutical intermediate.
Mikael Brink; Anders Dahlen; Thomas Olsson; Magnus Polla; Tor Svensson. Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa). Bioorganic & Medicinal Chemistry. 2014, 22,(7), 2261-2268.
Dichiarazioni di rischio (UE): H315-H319-H335
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Dichiarazioni precauzionali: P260-P201-P280g-P304+P340-P405-P501a
Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Wear protective gloves. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.